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Abstract
Delays between contrast agent (CA) arrival at the site of vascular input function 
(VIF) sampling and the tissue of interest affect dynamic contrast enhanced 
(DCE) MRI pharmacokinetic modelling. We investigate effects of altering 
VIF CA bolus arrival delays on liver DCE MRI perfusion parameters, propose 
an alternative approach to estimating delays and evaluate reproducibility.
Thirteen healthy volunteers (28.7  ±  1.9 years, seven males) underwent 
liver DCE MRI using dual-input single compartment modelling, with 
reproducibility (n  =  9) measured at 7 days. Effects of VIF CA bolus arrival 
delays were assessed for arterial and portal venous input functions. Delays were 
pre-estimated using linear regression, with restricted free modelling around 
the pre-estimated delay. Perfusion parameters and 7 days reproducibility were 
compared using this method, freely modelled delays and no delays using one-
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way ANOVA. Reproducibility was assessed using Bland–Altman analysis of 
agreement.
Maximum percent change relative to parameters obtained using zero 
delays, were  −31% for portal venous (PV) perfusion, +43% for total liver 
blood flow (TLBF), +3247% for hepatic arterial (HA) fraction, +150% 
for mean transit time and  −10% for distribution volume. Differences were 
demonstrated between the 3 methods for PV perfusion (p  =  0.0085) and HA 
fraction (p  <  0.0001), but not other parameters. Improved mean differences 
and Bland–Altman 95% Limits-of-Agreement for reproducibility of PV 
perfusion (9.3 ml/min/100 g, ±506.1 ml/min/100 g) and TLBF (43.8 ml/
min/100 g, ±586.7 ml/min/100 g) were demonstrated using pre-estimated 
delays with constrained free modelling.
CA bolus arrival delays cause profound differences in liver DCE MRI 
quantification. Pre-estimation of delays with constrained free modelling 
improved 7 days reproducibility of perfusion parameters in volunteers.
Keywords: Liver DCE MRI, liver perfusion, pharmacokinetic modelling
(Some figures may appear in colour only in the online journal)
Introduction
Dynamic contrast enhanced (DCE) MRI is an established technique for quantification of 
liver perfusion. After the intravenous administration of gadolinium-based contrast agent 
(CA), images are acquired at high temporal resolution and dynamic changes in tissue signal 
intensity (SI) over time are recorded. SI measurements are then converted to CA concen-
tration, before pharmacokinetic modelling of the uptake and washout of CA from the tis-
sues is used to characterise tissue perfusion (Tofts and Kermode 1991, Materne et al 2002, 
Pandharipande et al 2005). These measurements have been used both in the assessment of 
microvascular changes in fibrosis/cirrhosis (Annet et al 2003, Hagiwara et al 2008, Kim 
et al 2008) and for assessment of lesional vascularity and tumour angiogenesis (Jackson 
et al 2002).
Liver DCE MRI is uniquely complex because of the dual portal venous (PV) and hepatic 
arterial (HA) blood supply. Pharmacokinetic modelling is reliant on simultaneous measure-
ment of vascular input functions (VIFs) from regions-of-interest (ROIs) placed over afferent 
arterial and PV vessels. The modelling process convolves these functions with tissue enhance-
ment curves to derive inflow and outflow constants. CA boluses arrival times differ between 
the arterial input function (AIF), PV input function (PVIF) and the liver parenchyma—to cor-
rect for this, terms for VIF-tissue bolus arrival delays are included in the model (Materne et al 
2000, 2002, Miyazaki et al 2008).
Visual estimation of CA bolus arrival time is challenging because background noise can 
make appreciation of subtle SI changes difficult. Furthermore, limitations in the temporal 
resolution of the data acquisition can miss the exact CA bolus arrival time. Small changes in 
assumed AIF to tissue bolus arrival delays however cause major alterations in DCE comp-
uterised tomography (CT) estimated perfusion parameters, both within the liver (Miyazaki 
et al 2008) and other organs (Wu et al 2003). Additionally, VIF delays themselves are likely 
to be affected by the systemic and local haemodynamic changes induced by liver disease and 
would therefore be important to consider in the quantification process.
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Various approaches to dealing with these delays are reported in the literature, including 
assuming zero delay (Murase et al 2007, Miyazaki et al 2008), fixing the delay across subjects 
for one or both VIFs (Materne et al 2002, Annet et al 2003) or free modelling of one or both 
of the VIF delays (Hagiwara et al 2008, Kim et al 2008). Each approach has limitations: free 
modelling for example estimates delays to optimise model fitting, but the addition of variables 
can result in non-physiological delay parameters (e.g. PVIF CA bolus arriving before the AIF) 
to achieve good ‘mathematical model fits’(Sourbron and Buckley 2012). An individualised 
approach that uses raw data to inform estimates of VIF delays whilst constraining them with 
physiologically acceptable limits could prove useful in deriving more physiological and accu-
rate liver DCE MRI perfusion quantification.
In this study we investigate the effect of altering VIF CA bolus arrival delays on dual-input 
single compartment liver DCE MRI perfusion quantification in normal volunteers. Thereafter, 
we propose an alternative method to estimate AIF and PVIF CA bolus arrival delays and com-
pare the 7 days reproducibility of derived perfusion measurements with alternative methods.
Methods
Subjects and preparation
Local ethics committee approval was obtained and participants provided informed written 
consent. Volunteers were recruited via advertisement within the university campus and were 
eligible if (a) they had no MRI contraindication, (b) were not taking any long-term medication 
(excluding the oral contraceptive pill) and (c) had no documented history of previous liver 
or gastrointestinal disease. Fourteen volunteers were screened of which one was excluded 
because of claustrophobia. The final cohort consisted of seven males (aged 26.5  ±  1.4 years) 
and six females (aged 31.2  ±  2.6 years). Participants fasted for 6 h prior to MRI and avoided 
caffeinated fluids. A 19G cannula was sited in a peripheral upper limb vein in preparation 
for administration of contrast. The breathing protocol was then explained to subjects before 
entering the scanner by the study coordinator (radiology research fellow with 5 years experi-
ence). For reproducibility studies, nine subjects consented to be re-scanned 7 days after the 
original study following identical preparation and MRI protocol, at a comparable time of the 
day (within 2 h).
DCE MRI
Imaging was performed using a 3.0T scanner (Achieva, Philips Healthcare, Best, Netherlands) 
using a 16 channel body coil (SENSE XL-Torso, Philips Healthcare, Best, Netherlands). After 
initial anatomical imaging using a breath hold balanced steady-state free precession (SSFP) 
sequence, DCE studies were planned to ensure inclusion of the whole liver volume, retro-
peritoneal great vessels and the heart. A multi-flip angle T1 measurement was undertaken 
using three-dimensional (3D) gradient echo imaging at five different flip angles (5, 7, 10, 15 
and 20°), with phase based B1 mapping for B1 non-uniformity correction (Treier et al 2007). 
DCE imaging in the coronal plane to minimise inflow effects, was performed using a 3D 
gradient turbo field echo (TFE) imaging with spectral attenuated inversion recovery (SPAIR) 
fat suppression. Thirty overcontiguous slices were acquired, then interpolated to sixty, with a 
total dynamic scan time of 3.35 s per 15 cm volume, scanned sequentially for 5 min (sequence 
parameters given in table 1). After the first five volumes were acquired, ten ml of Gd-DOTA 
(gadoterate dimeglumine, Dotarem®, Guerbet, Roissy, France), diluted in 10 ml of normal 
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saline, was injected at 4 ml s−1 (Spectris®, Medrad Inc., USA), followed by a 20 ml saline 
flush. Subjects were given the first breath hold instruction before the CA injection: this mini-
mised the likelihood of motion artefact in the early part of the DCE study (including the VIF 
peaks). Thereafter they were asked to continue self-directed breath holds in expiration for the 
duration of the study.
Post-processing and data analysis
Post-processing was performed using Matlab code (MathWorks, Natick, USA) developed in 
house. DCE volumes corrupted by significant motion artefact noise were discarded (aver-
age of 21/90 volumes discarded). No VIF peaks were missed in discarded data sets. Five 
coronal slices centred around the portal vein, each separated by 10 mm were then selected 
for analysis. Each slice was matched to data from the previously derived T1 maps and reg-
istered using robust data decomposition registration to correct for tissue displacement and 
deformation (Hamy et al 2014). Missing SI data from discarded volumes was estimated using 
linear interpolation. The interval for interpolation only exceeded one discarded volume on 
two occasions, both well after VIF and parenchymal peak SIs. In these instances, interpolation 
for two successive discarded volumes took place. Pixel wise conversion of sequential post-
contrast SI into CA concentration was then undertaken using previously described methods 
for each of the five slices (Aronhime et al 2014, Gill et al 2014). Three parenchymal ROIs 
were positioned on each slice (total 15 ROIs), firstly in the right upper region (segments VII/
VIII), left liver (segments II/III) and right lower region (segments V/VI). Care was taken to 
ensure parenchymal ROIs excluded any major inflow or outflow vessels (HA, PV and hepatic 
venous radicles). ROIs were then also positioned within the left ventricle and PV to derive 
Table 1. Sequence parameters.
T1 multi-flip 
angle B1 map
dce mri (TFE with 
SPAIR fat suppression)
TR/TE (seconds) 4.0/2.0 100/1.0 2.3/1.0
Flip angle (°) 5, 7, 10, 15, 20 60 10
Matrix size (pixels) 240  ×  240 100  ×  100 240  ×  240
Field-of-view (mm) 475  ×  475 475  ×  475 475  ×  475
Spatial resolution 
(mm2)
1.98  ×  1.98 4.75  ×  4.75 1.98  ×  1.98
Bandwidth (Hz/
pixel)
389 1447 1411
Slice thickness 
(mm)
2.5 5 5
Slice gap (mm) — 5 —
Slices per volume 60 30 30 (interpolated to 60)
SPAIR inversion 
time (ms)
— — 56
Partial Fourier 
factor
— — 0.625
TFE shots — — 16
TFE shot duration 
(ms)
— — 209
Parallel imaging 
(SENSE) factors
2.9 RL, 1.4 AP
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each VIF (figure 1), as the left ventricle in our experience delivered more consistent VIFs. 
Perfusion parameters (detailed below) extracted from all fifteen ROIs (three ROIs on five 
slices) were averaged across all subjects for different post-processing method comparisons. 
All post-processing was undertaken by the study coordinator (radiology research fellow with 
5 years’ experience of abdominal MRI).
Pharmacokinetic modelling
Dual input single compartment modelling was undertaken as reported previously (Materne 
et al 2002, Hagiwara et al 2008). Briefly, liver parenchymal CA concentration as a function of 
time (C tL( )) can be expressed as:
C t k C t k C t te  d
t
k t t
L
0
1a a a 1p p p
2( ) [ ( ) ( )]  ( )∫ τ τ= − + −′ ′ ′− − ′ (1)
where C ta( ) represents the arterial input CA concentration as a function of time, C tp( ) repre-
sents the PV input CA concentration as a function of time, k1a represents the arterial inflow 
constant, k1p represents the PV inflow constant, k2 represents the outflow constant, aτ  represents 
the delay between the arrival of CA in the AIF and parenchymal ROIs and pτ  represents the 
delay between arrival of CA in the PVIF and parenchymal ROIs (figure 2(a)). Model fitting 
was undertaken using non-linear least squares fitting with in house developed Matlab code. 
Inflow and outflow constants were used to derive estimates of PV perfusion (ml/min/100 g), 
(TLBF, sum of HA and PV perfusion, ml/min/100 g), HA fraction (%), distribution volume 
(DV, %) and mean transit time (MTT, seconds) as reported previously (Materne et al 2002, 
Hagiwara et al 2008).
Effects of altering VIF CA bolus arrival delays
CA bolus arrival delays in the modelling process effectively shift the VIFs in the modelling 
process forward by increments defined by the temporal resolution of the data (3.35 s in this 
study) (figure 2(a)). To investigate the effects of altering AIF and PVIF CA bolus arrival 
delays, pharmacokinetic modelling was undertaken after introducing successive increments to 
Figure 1. Example of ROI placement for DCE MRI quantification. Intra-ventricular 
ROI placement for AIF (a), PV ROI placement of PVIF (b) and parenchymal ROI 
placement (c) for segments II/III (far left), segments V/VI (right lower) and segments 
VII/VIII (right upper). Parenchymal ROIs were placed in each of the three locations on 
five slices.
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aτ  (6 steps, up to 20.10 s) and pτ  (3 steps, up to 10.05 s) for each dataset (larger delays were not 
studied as these are less likely to be physiological). Perfusion parameters for each combina-
tion of VIF delays (n  =  18) were then averaged across subjects for analysis.
Alternative approaches to CA bolus arrival delays
Perfusion parameters and their 7 days reproducibility were then compared using the following 
methods for handling CA bolus arrival delays:
 (i) No delays
  Assuming no delay between VIFs and parenchymal enhancement (i.e. aτ  and pτ  both set 
to zero), fixed across all datasets (Murase et al 2007, Miyazaki et al 2008).
 (ii) Freely modelled delays
  Free (unconstrained) modelling of AIF and PVIF delays to optimise model fitting by 
minimising the residual sum of squares (Hagiwara et al 2008, Kim et al 2008).
 (iii) Pre-estimated delays with constrained free modelling
  The first five data points for VIF and parenchymal CA concentrations were used to 
determine the baseline pre-CA concentration for each curve. Linear regression between 
the first VIF data point exceeding the upper limit of the 95% confidence interval of 
baseline pre-CA concentration, and the VIF peak was undertaken for the AIF and PVIF. 
The VIF CA bolus arrival times (tC arrivala  and tC arrivalp ) were then each estimated as the 
Figure 2. τa, τp, and linear regression for pre-estimation of AIF and PVIF CA bolus 
arrival delays. (a) CA bolus arrival delays between the afferent vessel and the liver are 
shown for the aorta (τa) and PV (τp). Inclusion of delay parameters has the effect of 
shifting the AIF (blue arrow and blue dashed AIF) and PVIF (red arrow and red dashed 
AIF) forward, to eliminate the delay to parenchymal enhancement (green enhancement 
curve) before fitting the data to the model. (b) Enhancement data between the first data 
point above the 95% confidence interval of the baseline and the VIF upstroke peak was 
modelled using linear regression to estimate aortic (tC arrivala ) and PV (tC arrivalp ) CA bolus 
arrival times. Parenchymal CA arrival time (tC arrivalL ) was determined using the 95% 
upper limit confidence interval of baseline data. Pharmacokinetic modelling was then 
undertaken constraining τa and τp to the limits specified by (i) and (ii) respectively.
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point of  intercept of the regression line with the time axis. Parenchymal enhancement 
was less noisy because of larger ROI size and lower susceptibility to flow artefact. The 
parenchymal CA arrival time (tC arrivalL ) was then defined as the last data point before the 
parenchymal CA concentration exceeded the upper limit of the 95% confidence interval 
of the baseline pre-CA concentration. Figure  2(b) demonstrates the process in detail. 
Pre-estimates for aτ  and pτ  were then determined as:
τ = −′ t tC Ca arrival arrivalL a (2)
τ = −′ t tC Cp arrival arrivalL p (3)
  As aτ′  and τ′p represented estimates of VIF delays, limited by temporal resolution (3.35 s), 
the pre-estimates were then used to constrain the range in which pharmacokinetic free 
modelling of aτ  and pτ  could occur, to one time point before and one time point after each 
estimate (i.e. within a 6.7 s window).
Statistical analysis
To investigate the effect of altering AIF and PVIF CA bolus delays, calculated perfusion 
parameters for each delay were expressed as a percentage of those obtained when assuming 
zero delay between VIFs and parenchymal enhancement.
Kolmogorov–Smirnov tests were then used to confirm the normality of perfusion param-
eters derived (i) assuming no VIF delays (i.e. aτ  and pτ  both set to zero), (ii) freely modelled 
delays and (iii) pre-estimated delays with constrained free modelling. Repeated measures one-
way analysis of variance (ANOVA) with corrections for non-sphericity were used to compare 
perfusion parameters using each of the three approaches to VIF delay estimation. Post hoc 
Tukey’s test was then applied where significant differences were identified. Where variables 
were found not to be normally distributed, the Kruskal–Wallis test was used followed by post 
hoc Dunn’s test if significant differences were identified. Paired t-tests/Wilcoxon matched-
pairs signed rank tests as appropriate were used to compare VIF delay estimations obtained 
using freely modelled and pre-estimated delays with constrained free modelling. Seven-day 
reproducibility (n  =  9) was assessed using Bland–Altman (BA) analysis of agreement, with 
calculation of the mean difference (bias), 95% limits of agreement (LoA) and coefficients of 
variation. The threshold of statistical significance was defined to be p  <  0.05.
Results
Effects of altering VIF CA bolus arrival delays
Calculated perfusion parameters for each AIF and PVIF delay increment expressed as a 
percent age of those obtained when assuming zero delay (i.e. aτ  and pτ  set to zero) are shown 
in figure 3.
Estimated PV perfusion (figure 3(a)) decreased by as much as 31% (13.40 s AIF CA bolus 
arrival delay). Introducing PVIF CA bolus arrival delays increased PV perfusion by as much as 
30% (10.05 s delay). A similar trend was demonstrated for TLBF (figure 3(b)), with perfusion 
estimates decreasing by as much as 10% (10.05 s AIF CA bolus arrival delay). Introducing 
PVIF CA bolus arrival delays increased TLBF by as much as 43% (10.05 s delay).
Because of small HA fraction estimates obtained when assuming zero VIF CA bolus 
arrival delays, introduction of CA bolus delays for both AIF and PVIFs resulted in increases 
of as much as 3247% (13.40 s AIF delay, 10.05 s PVIF delay, figure 3(c)). MTT increased by 
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as much as 150% (0 s AIF delay, 10.05 s PVIF delay, figure 3(d)). DV reduced by up to 10% 
(0 s and 20.10 s AIF delay, 10.05 s PVIF delay, figure 3(e)).
Comparison of VIF delay estimation methods
Perfusion parameters calculated using each of the three methods are shown in table 2 and 
graphically in figure 4. HA fraction, DV and ‘τp’ were not normally distributed and underwent 
non-parametric statistical testing. Significant differences were demonstrated between the three 
methods for PV perfusion (F(1.25, 24.96)  =  7.29; p  =  0.0085) and HA fraction (H  =  23.94; 
p  <  0.0001), but there were no significant differences for the other parameters. Post hoc test-
ing demonstrated significant differences between zero CA bolus VIF arrival delays and freely 
modelled delays for both PV perfusion and HA fraction, but only for HA fraction when free 
modelling was constrained using pre-estimated delays. Significant differences were demon-
strated between freely modelled and pre-estimated delays with constrained free modelling for 
AIF (mean difference  −3.7  ±  1.1 s, p  =  0.0035) and PVIF CA bolus arrival delays (median 
difference 1.12 s, p  =  0.029).
τa(seconds)
%
ch
an
ge
0 .0
0
3.3
5
6.7
0
10.
05
13.
40
16.
75
20.
10
-60
-40
-20
0
20
40
60
τp= 0 s
τp= 3.35 s
τp= 6.70 s
τp=10.05s
τa(seconds)
%
ch
an
ge
0.0
0
3.3
5
6.7
0
10.
05
13.
40
16.
75
20.
10
-20
0
20
40
60
80
τp= 0 s
τp= 3.35 s
τp= 6.70 s
τp= 10.05 s
τa(seconds)
%
ch
an
ge
0.0
0
3.3
5
6.7
0
10.
05
13.
40
16.
75
20.
10
0
1000
2000
3000
4000
5000
τp= 0 s
τp= 3.35 s
τp= 6.70 s
τp= 10.05 s
τ a(seconds)
%
ch
an
ge
0.0
0
3.3
5
6.7
0
10.
05
13.
40
16.
75
20.
10
-100
0
100
200
300
400
τp= 0 s
τp= 3.35 s
τp= 6.70 s
τp= 10.05 s
τa(seconds)
%
ch
an
ge
0.0
0
3.3
5
6.7
0
10.
05
13.
40
16.
75
20.
10
-30
-20
-10
0
10
20
τp= 0 s
τp= 3.35 s
τp= 6.70 s
τp= 10.05 s
(b)(a)
(c)
(e)
(d)
Figure 3. Effects of changes in CA bolus arrival delays on dual input single compartment 
parameter estimation. Percentage change relative to parameters calculated using zero 
CA bolus arrival delays are demonstrated for CA bolus arrival delays upto 20.10 s (τa) 
and 10.05 s (τp), for (a) PV perfusion, (b) TLBF, (c) HA fraction, (d) MTT and (e) DV.
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Reproducibility studies
Reproducibility was assessed in 9 normal volunteers 7 days after the initial study (table 3, 
figures 5 and 6). The mean difference and BA 95% LoAs for repeated PV perfusion and TLBF 
measurements were smallest using pre-estimated delays with constrained free modelling. The 
coefficient of variation using this method was similar to unconstrained free modelling for both 
parameters.
The mean difference and BA 95% LoAs between repeated HA fraction measurements 
was smallest using no delays. The coefficient of variation was smallest using freely modelled 
delays. The smallest mean difference for repeated MTT and DV measurements was demon-
strated using freely modelled delays. BA 95% LoAs and coefficients of variation were similar 
across all three methods for both MTT and DV (table 3).
Discussion
We have investigated the effects of CA bolus arrival delays on pharmacokinetic parameter 
estimation using non-simulated human liver DCE MRI data. The perfusion parameter varia-
tion driven by changes in CA bolus arrival delay parameters underlines the importance of 
proper consideration of delays in the quantification process. A robust method to measure these 
accurately and consistently across thousands of pixels, each with physiological (as a result of 
distance from VIF ROIs) and pathological variations (as in the case of focal lesions or hetero-
geneous diffuse liver disease) in CA bolus arrival delay is essential.
Based on our data, we would propose pre-estimation of delays with constrained free mod-
elling as a useful strategy. Whilst the coefficients of variation of freely modelled delays and 
pre-estimated delays with constrained free modelling are similar across all perfusion param-
eters, the improved reproducibility of absolute perfusion parameters (i.e. PV perfusion and 
TLBF), as demonstrated by BA 95% LoAs is a major strength. These are the most con-
ceptually useful clinical parameters with potential as vascular biomarkers of liver function 
(Chouhan et al 2016). Such improvements, especially when arising from more physiological 
estimates of bolus arrival delay represent a clinically useful development relative to the use 
of freely modelling.
Table 2. Perfusion parameters estimated using the dual input single compartment 
model, with each method of VIF delay estimation.
No delays
Freely modelled 
delays
Pre-estimated delays with 
constrained free modelling
PV perfusion  
(ml/min/100 g)a
351.9  ±  55.1 262.7  ±  37.4b 274.3  ±  38.4
TLBF (ml/
min/100 g)
367.3  ±  54.6 321.0  ±  41.2 327.5  ±  41.7
HA fraction (%)a 7.4  ±  2.3 21.7  ±  3.6b 20.7  ±  3.7b
Mean transit time 
(seconds)
18.6  ±  2.7 20.0  ±  2.7 19.9  ±  2.6
Distribution 
volume (%)
71.2  ±  4.3 74.1  ±  3.9 73.5  ±  4.0
τa (seconds)a — 16.1  ±  1.3 12.5  ±  1.1
τp (seconds)a — 1.9  ±  0.7 2.6  ±  0.5
a One-way ANOVA/Kruskal–Wallis/paired t-test/Wilcoxon rank p  <  0.05.
b Post hoc Tukey test comparison with no delays p  <  0.05.
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Figure 4. Perfusion parameters estimated using the dual input single compartment 
model, with each method of VIF delay estimation. p-values are quoted for one-way 
ANOVA/Kruskal–Wallis tests and paired t-tests/Wilcoxon matched-pairs signed 
rank tests where appropriate, with significant differences on post hoc testing (*), for 
no delays,  freely modelled delays and pre-estimated delays with constrained free 
modelling ((a)–(e)). Comparisons of delay parameters were only undertaken when 
these were modelled (f ) and (g).
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Table 3. Summary of reproducibility of perfusion parameters estimated using 
alternative approaches to VIF delays with dual input single compartment modelling 
alongside PCMRI reproducibility.
No  
delays
Freely modelled 
delays
Pre-estimated delays 
with constrained 
free modelling
PV perfusion (ml/min/100 g)
  Mean difference 52.9 40.1 9.3
  BA 95% LoA ±776.6 ±570.6 ±506.1
  Coefficient of variation 71.8% 65.2% 64.1%
TLBF (ml/min/100 g)
  Mean difference 58.6 69.6 43.8
  BA 95% LoA ±773.8 ±633.6 ±586.7
  Coefficient of variation 68.2% 58.9% 58.3%
HA fraction (%)
  Mean difference 5.1 6.3 9.3
  BA 95% LoA ±28.3 ±39.6 ±35.5
  Coefficient of variation 145.3% 76.4% 81.7%
Mean transit time (seconds)
  Mean difference 4.0 0.8 2.4
  BA 95% LoA ±24.8 ±26.8 ±26.9
  Coefficient of variation 65.6% 61.3% 60.8%
Distribution volume (%)
  Mean difference 14.2 13.4 14.1
  BA 95% LoA ±49.9 ±49.5 ±48.2
  Coefficient of variation 27.8% 23.8% 24.7%
Note: Emboldened values in the table highlight the best performing method for each statistic.
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Figure 5. Analysis of agreement of absolute perfusion parameters using alternative 
approaches to VIF delays with dual input single compartment modelling. Bland–Altman 
analysis of PV perfusion (upper row) and TLBF (lower row) using ((a) and (d)) zero 
VIF delays, ((b) and (e)) free modelling of VIF delays and ((c) and (f )) constrained free 
modelling of pre-estimated VIF delays.
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The reproducibility of HA fraction using our proposed method is disappointing but is likely 
related to underestimation of HA fraction when using no CA bolus arrival delays. Similar 
reproducibility across the three methods for MTT and DV is likely accounted for by their 
reliance on the outflow constant (k2). The latter is less affected by CA bolus arrival time and 
more reliant on the tail portions of enhancement curves. The clinical value of MTT and DV 
in the context of liver pathology are not fully understood but changes in PV perfusion and 
TLBF would have potential use in the vascular assessment of liver disease (e.g. measurement 
of the HA buffer response (Lautt 2007) or critical hypoperfusion in liver failure (Mehta et al 
2014)), or in the assessment of lesional vascularity and tumour angiogenesis (Annet et  al 
2003, Abdullah et al 2008, Hagiwara et al 2008, Patel et al 2010, Ferl and Port 2012, Cao 
et al 2013).
Although a strength of our study is the use of prospectively acquired human DCE data, 
there are limitations. We had no standard of reference for liver perfusion parameters and 
therefore cannot determine which method is most accurate. To overcome this, we compared 
methods using 7 days reproducibility. We also acknowledge that by expressing the effects of 
changes in CA bolus arrival delays using percent change, the effect small absolute increments 
in low absolute values can be exaggerated (as in the case of HA fraction). It is also of note 
that changes in TLBF are expectably similar to those recorded for PV perfusion, as TLBF is 
predominantly composed of PV perfusion. Finally there is limited published data on the repro-
ducibility of liver DCE MRI using dual-input single compartment modelling, but our data 
demonstrates relatively wide BA 95% LoAs and coefficients of variation for perfusion param-
eters. Aronhime et al for example, reported comparably wide coefficients of variation of 58%, 
39%, 73% and 15% for PV perfusion, TLBF, HA fraction and DV respectively (Aronhime 
et  al 2014). While we acknowledge that weak reproducibility does undermine the clinical 
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Figure 6. Analysis of agreement of relative perfusion parameters using alternative 
approaches to VIF delays with dual input single compartment modelling. Bland–Altman 
analysis of HA fraction (upper row), MTT (middle row) and DV (lower row) using ((a), 
(d) and (g)) zero VIF delays, ((b), (e) and (h)) free modelling of VIF delays and ((c), (f ) 
and (i)) constrained free modelling of pre-estimated VIF delays.
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utility of liver DCE MRI, we believe this may reflect natural variation in perfusion, contingent 
on differences in subject hydration, but also the many other challenges in performing clinical 
DCE MRI not directly addressed by the present study.
Several methodological details have the potential to significantly affect quantification. All 
delay estimations (for freely modelled and pre-estimated delays with constrained free model-
ling) are restricted to unit shifts defined by the temporal resolution of the data (in this study, 
3.35 s). Accurate T1 measurements for example, are essential. Our use of multi-flip angle 
T1 measurements with phase-based B1 mapping/B1 non-uniformity correction is not without 
error, but based on prior experience deemed suitable for this application (Barnes et al 2014). 
Post-processing is also heavily reliant on complex computation and intensive human input. 
Discarding on average 21/90 volumes though not unexpected (assuming an average breath 
hold of 15 s, equating to 20 inspiration/expiration cycles over 5 min) could also affect quantifi-
cation. The use of linear interpolation, motion correction, slice selection for analysis and ROI 
positioning also have the potential to affect results.
Conclusion
We have shown that differences in CA bolus arrival delays can cause profound differences in 
dual-input single compartment modelled hepatic perfusion parameters. Such variations are a 
major barrier to cross-institution large-scale studies required to determine the clinical value of 
liver DCE MRI, and develop it as a universal tool. As a solution, we propose a simple method 
for estimation of AIF and PVIF CA bolus arrival delays to optimise model fitting within 
physiologically viable estimates of delays. We have demonstrated that this method produces 
similar perfusion parameter estimates to freely modelled CA bolus arrival delays, improves 
the reproducibility of PV perfusion and TLBF and provides comparable reproducibility to 
freely modelled delays for HA fraction, MTT and DV.
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